// IP Marketing video - START// IP Marketing video - END

Drugs giant Novartis posts $2.08 billion Q4 net profit

Drugs giant Novartis posts $2.08 billion Q4 net profit

PanARMENIAN.Net - Swiss drug maker Novartis AG has reported a fourth-quarter net profit of $2.08 billion, AP said.

The result is 72 percent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million after ending its clinical study into wider uses of the hypertension drug Tekturna.

Novartis said Wednesday, January 23 that fourth-quarter sales in 2012 were almost flat at $14.83 billion compared with $14.78 billion in the same period the previous year.

The company also said that long-time chairman and former chief executive Daniel Vasella will leave the board at the next shareholders' meeting at the end of February.

 Top stories
The foreign debt makes up around $4.5 billion, including the government’s $3.99 billion and the Central Bank’s $502.4 million debts.
The official said that the EU countries have already issued a mandate for negotiating a corresponding document.
Iran plans to increase natural gas exports to Armenia from 1 million cubic meters per day to 3 million cubic meters in the next few years.
“The two sides are currently preparing the required infrastructure for boosting natural gas exchange,” NIGEC chief Alireza Kameli said.
Partner news